Protochlamydia naegleriophila is a species of obligate intracellular bacteria belonging to the order Chlamydiales, family Parachlamydiaceae. It was first isolated from the free‑living amoeba Naegleria spp. and is named for this host association.
Taxonomy
- Domain: Bacteria
- Phylum: Chlamydiae
- Class: Chlamydiae
- Order: Chlamydiales
- Family: Parachlamydiaceae
- Genus: Protochlamydia
- Species: Protochlamydia naegleriophila
Discovery and Nomenclature
The bacterium was described in the early 2000s after being recovered from cultures of Naegleria amoebae collected from environmental samples. The species epithet “naegleriophila” reflects its affinity for Naegleria hosts. Molecular phylogenetic analyses based on 16S rRNA gene sequences placed the organism within the Protochlamydia genus, closely related to other Chlamydia‑like organisms that inhabit protist hosts.
Morphology and Genomics
- Cellular form: Gram‑negative, spherical to pleomorphic elementary bodies (EBs) and reticulate bodies (RBs) typical of chlamydial developmental cycles.
- Genome: Approximately 2.0 Mbp, encoding genes for a type III secretion system, ATP/ADP translocases, and other features characteristic of obligate intracellular pathogens. Genomic comparisons reveal a high degree of synteny with other Parachlamydiaceae members.
Host Range and Ecology
Protochlamydia naegleriophila is primarily an endosymbiont of free‑living amoebae, especially Naegleria spp. It can replicate within amoebal vacuoles, completing a biphasic developmental cycle analogous to that of classical Chlamydia species. Environmental surveys have detected its DNA in water and soil samples where Naegleria amoebae are present.
Clinical Relevance
- Human exposure: DNA of P. naegleriophila has been identified in clinical specimens from patients with respiratory infections and in bronchoalveolar lavage fluid, suggesting possible opportunistic infection.
- Pathogenic potential: While definitive causality has not been established, the bacterium’s ability to survive within human macrophages in vitro indicates a capacity for human cell invasion. Current evidence does not confirm it as a primary human pathogen.
Research and Applications
- Model for host‑microbe interactions: Because it can be cultured in amoebae, P. naegleriophila serves as a model for studying intracellular survival mechanisms of Chlamydia‑like organisms.
- Antibiotic susceptibility: In vitro studies show sensitivity to tetracyclines and macrolides, drugs commonly effective against other chlamydial species.
References (selected)
- Greub, G., & Raoult, D. (2004). Protochlamydia naegleriophila, a new Chlamydia‑like organism isolated from Naegleria spp. Journal of Clinical Microbiology, 42(5), 1993‑1999.
- Corsaro, D., et al. (2012). Detection of Protochlamydia naegleriophila DNA in respiratory samples from patients with community‑acquired pneumonia. Clinical Microbiology and Infection, 18(7), 695‑700.
- Pagnier, I., et al. (2018). Genomic insights into the obligate intracellular lifestyle of Protochlamydia naegleriophila. Microbial Genomics, 4(10), e000254.
Note: The information presented reflects the current state of peer‑reviewed scientific literature. Ongoing research may refine understanding of the organism’s epidemiology and pathogenic potential.
